Danaher Announces Pricing Of Senior Notes Offering

WASHINGTON, Oct. 29, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”) announced today that its wholly owned subsidiary, DH Europe Finance II S.à r.l. (“Danaher International II”), has priced an offering of: $700,000,000 principal amount of 2.050% senior notes due 2022 at an offering price of 99.994% of the principal amount; $700,000,000 principal amount of 2.200%... Read more

Danaher To Present At Baird Global Industrial Conference

WASHINGTON, Oct. 28, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Baird Global Industrial Conference in Chicago on Tuesday, November 5, 2019 at 10:30 a.m. CT. The audio will be simultaneously webcast on and the presentation will be archived on  www.danaher.com. ... Read more

Danaher Reports Third Quarter 2019 Results

WASHINGTON, Oct. 24, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) today announced results for the third quarter 2019. For the quarter ended September 27, 2019, net earnings attributable to Danaher common stockholders were $648.4 million, or $0.89 per diluted share which represents a 4.5% year-over-year decrease from the comparable 2018 period. Non-GAAP adjusted diluted net earnings... Read more

Sartorius Stedim Biotech signs agreement to acquire select Danaher Life Science platform businesses

Aubagne, October 21, 2019 The proposed transaction is part of the sale of a larger portfolio of businesses from Danaher to SSB’s major shareholder Sartorius Group Includes chromatography hardware and resins, and microcarriers (SoloHill) businesses Complements SSB’s strong position in the fast-growing bioprocessing market Agreement is subject to acquisition of the GE Biopharma business by... Read more

Danaher Reaches Agreement To Sell Certain Businesses To Sartorius AG As Part Of The GE Biopharma Acquisition Regulatory Process

Danaher Reaches Agreement To Sell Certain Businesses To Sartorius AG As Part Of The GE Biopharma Acquisition Regulatory Process WASHINGTON, Oct. 21, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) today announced that it has signed an agreement to sell its label-free biomolecular characterization, chromatography hardware and resins, and microcarriers and particle validation standards businesses to... Read more

Danaher Schedules Third Quarter 2019 Earnings Conference Call

WASHINGTON, Oct. 9, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the third quarter 2019 on Thursday, October 24, 2019 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section of Danaher’s... Read more

Danaher Announces Redemption Of Senior Notes

WASHINGTON, Sept. 23, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”) announced today that it will redeem all of its $500,000,000 aggregate principal amount of 2.400% Senior Notes due 2020 (the “Danaher 2020 Notes”) and all of the $375,000,000 aggregate principal amount of 5.00% Senior Notes due 2020 originally issued by Pall Corporation and subsequently guaranteed... Read more

Envista Announces IPO Closing

BREA, Calif., Sept. 20, 2019 /PRNewswire/ — Envista Holdings Corporation, a subsidiary of Danaher Corporation (NYSE: DHR), today announced the closing of its previously announced initial public offering (IPO) of 26,768,000 shares of its common stock at a price to the public of $22.00 per share. In connection with the IPO, the underwriters exercised in... Read more

Envista Announces Pricing of Initial Public Offering

BREA, Calif., Sept. 17, 2019 /PRNewswire/ — Envista Holdings Corporation, a subsidiary of Danaher Corporation (NYSE: DHR), announced today the pricing of its initial public offering (IPO) of 26,768,000 shares of its common stock at a price to the public of $22.00 per share. The shares are expected to begin trading on the New York Stock... Read more

Danaher Announces Quarterly Dividend

WASHINGTON, Sept. 10, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.17 per share of its common stock, payable on October 25, 2019 to holders of record on September 27, 2019. In addition, Danaher announced today that its Board of Directors... Read more